FDA Grants 510(k) Clearance to the Diazyme Colorimetric Lithium Assay
30th Dec 2025
SAN DIEGO, CA - 30 December 2025 - Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(K) clearances to market the Diazyme Colorimetric Lithium Assay.
Diazyme Colorimetric Lithium Assay kit is for quantitative in vitro determination of lithium in human serum or EDTA plasma. Measurements of Lithium are carried out to ensure that proper drug do
…